Viewing Study NCT01066793


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-05-17 @ 11:07 PM
Study NCT ID: NCT01066793
Status: COMPLETED
Last Update Posted: 2016-05-09
First Post: 2010-02-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: PROPHESYS 2: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b
Sponsor: Hoffmann-La Roche
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: MV21020
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators